Cognitive Performance Research Stack

$209.00

In stock
COA-verified
≥99% purity.
USA manufactured.
In stock
COA-verified
≥99% purity.
USA manufactured.
COA-verified
In stock
≥99% purity.
USA manufactured.
In stock
≥99% purity.
USA manufactured.
In stock
≥99% purity.
USA manufactured.
In stock
≥99% purity.
USA manufactured.

What Is Cognitive Performance Research Stack

A two-compound neuropeptide research stack for investigating neurotrophic signaling, GABA-related modulation, stress-response pathways, monoamine systems, and functional neural connectivity.

COMPONENT

Selank

Semax

QUANTITY

10mg × 2

RESEARCH CLASS

taftsin-derived regulatory peptide research

ACTH(4-7)-derived regulatory peptide research

The Cognitive Performance Research Stack contains Selank and Semax, two synthetic regulatory peptides developed from different endogenous peptide motifs. Selank is a heptapeptide derived from the immunomodulatory peptide tuftsin and is studied in GABAergic, stress-response, cytokine, and functional-connectivity models. Semax is an ACTH-fragment analog studied in neurotrophic signaling, monoamine regulation, gene expression, and experimental models of neural stress.
The evidence base is largely preclinical and region-specific. The compounds are supplied only for laboratory research, and this stack does not represent an approved cognitive or neurological treatment.

GABA receptor binding and inhibitory neurotransmission models
BDNF/TrkB and neurotrophic gene-expression research
Dopaminergic and serotonergic pathway investigation
Stress-response, anxiety-model, and behavioral neuroscience research
Resting-state functional-connectivity and systems-neuroscience models

Semax was developed as a stabilized analog derived from the ACTH(4-10) region, with research emphasizing neurotrophic and neuroprotective pathways rather than corticosteroid activity. Selank was developed from a tuftsin-related sequence and became a subject of research involving anxiety models, immune-neural signaling, and GABAergic modulation. Both compounds have been investigated extensively in Russian and Eastern European research programs.

Reserch-grade coenzyme compound visualization.

COMPOUND

Selank + Semax

TYPE

Multi-component neuropeptide and cognitive pathway research stack

MOLECULAR FORMULA

Not applicable (multi-component formulation)

MOLECULAR WEIGHT

Not applicable (individual component molecular weights vary)

PURITY

≥99%

ANALYSIS

HPLC Verified

STORAGE

Store at -20°C. Protect from light and moisture.

CLASSIFICATION

Reserch Use Only

Research Findings

Published and preclinical research relevant to the individual components covers several areas of scientific investigation, including:

Selank signaling: Laboratory studies examine GABA receptor modulation, cytokine expression, stress response, and anxiety-related behavioral models.
Semax signaling: Research explores BDNF/TrkB expression, monoamine systems, neurotrophic pathways, and gene regulation.
Functional connectivity: Neuroimaging research has compared changes in resting-state connectivity following Selank and Semax exposure.
Comparative neuropeptide research: The stack supports separate analysis of tuftsin-derived and ACTH-fragment-derived signaling mechanisms.

References

1. Vyunova TV, et al. (2018). The molecular aspects of heptapeptide Selank biological activity. Current Protein & Peptide Science, 19(12), 1208–1218. https://doi.org/10.2174/1389203718666170807121527

2. Dolotov OV, et al. (2006). Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research, 1117(1), 54–60. https://doi.org/10.1016/j.brainres.2006.07.108

3. Medvedeva EV, et al. (2020). Functional connectomic approach to studying Selank and Semax action. Doklady Biological Sciences, 490, 18–21. https://doi.org/10.1134/S0012496620010032

4. Kost NV, et al. (2001). Semax and Selank inhibit enkephalin-degrading enzymes from human serum. Bulletin of Experimental Biology and Medicine, 131(5), 429–431. https://doi.org/10.1023/A:1017922029086

FAQ

What type of research is this stack used for?

Cognitive Performance Research Stack is intended for controlled in vitro, analytical, and preclinical laboratory research involving the pathways described on this page. Experimental design should address each component independently.

Where is BioRhex’s Cognitive Performance Research Stack manufactured?

All BioRhex compounds included in this stack are manufactured in a GMP-compliant facility located in the United States.

What testing does BioRhex conduct on the included compounds?

Each applicable batch undergoes third-party HPLC purity testing, mass spectrometry identity verification, and sterility testing. Batch-specific Certificates of Analysis are included or made available for the individual components.

Does the stack have one molecular formula or one Certificate of Analysis?

No. A stack contains multiple independent compounds. Each component has its own molecular identity, batch number, test results, and Certificate of Analysis.

Is this stack approved for human use?

No. The compounds in this stack are not supplied for human or animal administration. They are provided exclusively for laboratory research purposes.

All BioRhex compounds in the Cognitive Performance Research Stack are supplied strictly for laboratory research purposes. Not for human or animal consumption, medical use, diagnostic use, or therapeutic application. The compounds are not represented as FDA-approved for the uses described on this page. Nothing in this document should be interpreted as health guidance, dosage guidance, or a recommendation for use outside controlled research settings.